Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications utilization cost mammography screening among commercially insured women 50 64 years
Kenneth Rothman Receives Career Accomplishment Award from Society for Epidemiologic Research Share on: June 26, 2017 RTI Health Solutions is pleased to announce that Ken Rothman , DrPH, Distinguished Fellow and Vice President for Epidemiology Research , …
… Venereology (EADV) Congress. Assessing humanistic burden among patients with moderate to severe psoriasis in the … Evaluating prevalence and consequence of residual disease among patients with moderate to severe psoriasis in the …
… first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2− advanced breast cancer in … KL, Broughton EI. Poster Real-world clinical outcomes among patients (pts) with metastatic/advanced triple-negative …
… Andrea Margulis Pharmacoepidemiology and Risk Management Women's Health Diabetes & Endocrine Disorders Telecommuter - … has experience in literature reviews; meta-analyses; drug utilization, case-control and cohort studies; methods …
… Valerie Williams Patient-Centered Outcomes Assessment Women's Health Psychiatry Gastroenterology Headquarters - … Outcomes Assessment group at RTI-HS. She has 30 years of experience applying psychometric and statistical … of applications, including substance abuse, health care utilization, and various psychological disorders; she has …
… create reports for regulatory and HTA purposes as well as publications, interactive tools, and models to help you …
… cancer. The study focused on Medicare patients aged 65 years and older and used a robust quasi-experimental study … patients with HR+/HER2– metastatic breast cancer. Links to publications: Goyal RK, Chen H, Abughosh SM, Holmes HM, … Johnson ML. Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2– metastatic …
… to relieve symptoms) How long symptom relief would last Cost Overall, respondents placed the most importance on …
… be presented at the 2023 Canadian Immunization Conference. Cost-effectiveness and public health impact of recombinant …
… from the Universitat Politècnica de Catalunya and has 18 years of experience working as a statistician for research … trials and epidemiologic studies. He has coauthored over 50 publications in the peer-reviewed medical literature and has …